Evidence map›Paper›PMID 33686371›Full record

ReviewSustainable chemistry and pharmacy2021

Green chemistry and coronavirus.

Sepideh Ahmadi, Navid Rabiee, Yousef Fatahi, Seyyed Emad Hooshmand, Mojtaba Bagherzadeh, Mohammad Rabiee, Vahid Jajarmi, Rassoul Dinarvand, Sajjad Habibzadeh, Mohammad Reza Saeb and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in Sustainable chemistry and pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Quantum dots against SARS-CoV-2: diagnostic and therapeutic potentials.Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986) · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Antimicrobial Susceptibility Pattern ofInfectious disease reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 5 countries.

Sepideh AhmadiStudent Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Navid RabieeDepartment of Chemistry, Sharif University of Technology, Tehran, Iran.
Yousef FatahiDepartment of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Seyyed Emad HooshmandDepartment of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mojtaba BagherzadehDepartment of Chemistry, Sharif University of Technology, Tehran, Iran.
Mohammad RabieeBiomaterial Group, Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran.
Vahid JajarmiDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rassoul DinarvandDepartment of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Sajjad HabibzadehDepartment of Chemical Engineering, Amirkabir University of Technology, Tehran, Iran.
Mohammad Reza SaebUniversité de Lorraine, CentraleSupélec, LMOPS, F-57000, Metz, France.
Rajender S VarmaRegional Centre of Advanced Technologies and Materials, Palacky University, Šlechtitelů 27, 783 71, Olomouc, Czech Republic.
Mohammadreza ShokouhimehrDepartment of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea.
Michael R HamblinLaser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, 2028, South Africa.
Amirkabir University of Technology · IRShahid Beheshti University of Medical Sciences · IRSharif University of Technology · IRCentraleSupélec · FRIran University of Medical Sciences · IRRegional Centre of Advanced Technologies and Materials · CZSeoul National University · KRTehran University of Medical Sciences · IRUniversal Scientific Education and Research Network · IRUniversity of Johannesburg · ZA

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract InfectionsR21AI121700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2016 to 2017
$462k
NIAID NIH HHS R01 AI050875NIAID NIH HHS R21 AI121700
6 · The paper itself

Abstract

The novel coronavirus pandemic has rapidly spread around the world since December 2019. Various techniques have been applied in identification of SARS-CoV-2 or COVID-19 infection including computed tomography imaging, whole genome sequencing, and molecular methods such as reverse transcription polymerase chain reaction (RT-PCR). This review article discusses the diagnostic methods currently being deployed for the SARS-CoV-2 identification including optical biosensors and point-of-care diagnostics that are on the horizon. These innovative technologies may provide a more accurate, sensitive and rapid diagnosis of SARS-CoV-2 to manage the present novel coronavirus outbreak, and could be beneficial in preventing any future epidemics. Furthermore, the use of green synthesized nanomaterials in the optical biosensor devices could leads to sustainable and environmentally-friendly approaches for addressing this crisis.

Indexed as

COVID-19Early diagnosisOptical biosensorPoint-of-careSARS-CoV-2

Identifiers

PMID33686371
PMCPMC7927595
OpenAlexW3133742528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.